YAKUGAKU ZASSHI 1979-12-01

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].

T Shindo, Y Yasuda, K Taira, N Mitani, A Kanda, A Akazawa

文献索引：Yakugaku Zasshi 99(12) , 1186-200, (1979)

全文：HTML全文

摘要